A case of biologic use in acute asthma exacerbation refractory to conventional management.
作者信息
Kim Bo-Guen, Park Dong Won, Park Tai Sun, Moon Ji-Yong, Kim Tae-Hyung, Kim Sang-Heon, Sohn Jang Won, Yoon Ho Joo, Lee Hyun
机构信息
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
出版信息
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2922-2925. doi: 10.1016/j.jaip.2023.06.064. Epub 2023 Jul 8.
PMID:37429420
Abstract
摘要
相似文献
1
A case of biologic use in acute asthma exacerbation refractory to conventional management.
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2922-2925. doi: 10.1016/j.jaip.2023.06.064. Epub 2023 Jul 8.
2
Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
Chin Med J (Engl). 2018 May 5;131(9):1009-1012. doi: 10.4103/0366-6999.230742.
3
Persistence of asthma biologic use in a US claims database.
Ann Allergy Asthma Immunol. 2021 Dec;127(6):648-654. doi: 10.1016/j.anai.2021.04.026. Epub 2021 May 7.
4
Adherence to Asthma Biologics: Implications for Patient Selection, Step Therapy, and Outcomes.
Chest. 2021 Mar;159(3):924-932. doi: 10.1016/j.chest.2020.10.050. Epub 2020 Oct 24.
5
Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
Ann Allergy Asthma Immunol. 2021 Sep;127(3):318-325.e2. doi: 10.1016/j.anai.2021.03.015. Epub 2021 Mar 26.
6
The use of biologic therapies for the management of pediatric asthma.
Pediatr Pulmonol. 2020 Mar;55(3):803-808. doi: 10.1002/ppul.24613. Epub 2019 Dec 27.
7
[Biologics in asthma: what's new?].
Rev Med Suisse. 2015 Jan 14;11(456-457):20, 22-4.
8
Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
Immunol Allergy Clin North Am. 2015 Feb;35(1):129-44. doi: 10.1016/j.iac.2014.09.005. Epub 2014 Nov 21.
9
What is the current role of biologics in the management of patients with severe refractory asthma?
Ann Allergy Asthma Immunol. 2016 May;116(5):383-7. doi: 10.1016/j.anai.2016.03.021.
10
Biologic logistics: Connecting with patients taking biologics.
Ann Allergy Asthma Immunol. 2020 Apr;124(4):309-310. doi: 10.1016/j.anai.2020.01.017. Epub 2020 Feb 14.
引用本文的文献
1
Insights and considerations in the use of biologics for managing eosinophilic exacerbations in asthma and chronic obstructive pulmonary disease.
J Thorac Dis. 2025 Apr 30;17(4):1795-1797. doi: 10.21037/jtd-2024-2206. Epub 2025 Apr 28.
Zotero 插件